NEU neuren pharmaceuticals limited

Ann: Preliminary Final Report, page-10

  1. 200 Posts.
    lightbulb Created with Sketch.  1
    PBT failed a clinical trial. Neuren hasn't yet. Unless we fail a trial the two companies stock charts are not comparable.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
$16.30
Change
-0.200(1.21%)
Mkt cap ! $2.084B
Open High Low Volume
$16.57 $16.65 $16.17 20.28K

Buyers (Bids)

Vol. Price($)
12 $16.28
 

Sellers (Offers)

Price($) Vol.
$16.31 68
Last trade - 10.11am 14/07/2026 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.